In the present study, alterations of serum visfatin, resistin and chemerin were studied in T2DM patients coexisting with clinical and subclinical thyroid dysfunctions, and their associations with thyroid hormones and inflammatory markers were evaluated. This evidence concerns the gene RETN and type 2 diabetes mellitus.